Novartis will acquire UK-based Myricx Bio for up to $1.5 billion, including $1.1 billion upfront and $400 million in ...

Rejuvenate Bio, a biotechnology company developing gene therapies for age-related and chronic diseases, today announced the ...

Rejuvenate Bio, a biotechnology company developing gene therapies for age-related and chronic diseases, today announced the closing of a $6 million financing round led by VCapital, with participation ...

The deal for the privately held U.K.-based biotechnology firm will help bolster Novartis’s oncology capabilities.

A surprising finding has revealed that the kidneys may control water retention through an additional pathway beyond the one ...

Preclinical realities, therapeutic momentum, and generative AI in drug discovery ...

NEW YORK, June 25, 2026 Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the ...

Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision ...

June 30 (Reuters) - Hong Kong-listed drug design tech firm Metis TechBio said on Tuesday it has granted U.S.-based biotechnology firm Boulevard Bio exclusive global rights to develop, manufacture and ...

India will inaugurate its first integrated bio-ethanol refinery on Friday (4 July) in Bargarh district, Odisha, marking a ...

A fresh wave of commitments to pure sciences marks a turning point in the way India's wealthy are giving.

Learn why OpenAI's ChatGPT 5.6 release is limited to a preview, highlighting its advanced reasoning, unsettling agent behavior, and regulatory implications.